Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 12;332(18):1578-1580.
doi: 10.1001/jama.2024.18575.

Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems

Lina Steinrud Mørch  1 , Amani Meaidi  1 , Giulia Corn  2 , Marie Hargreave  3 , Charlotte Wessel Skovlund  1
Affiliations

Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems

Lina Steinrud Mørch et al. JAMA. .
No abstract available

Plain language summary

This study uses data from nationwide Danish registries to assess breast cancer risk with continuous use of levonorgestrel-releasing intrauterine systems, accounting for other hormonal exposures.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Similar articles

See all similar articles

References

    1. Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard Ø. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017;377(23):2228-2239. doi:10.1056/NEJMoa1700732 - DOI - PubMed
    1. Backman T, Rauramo I, Jaakkola K, et al. . Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol. 2005;106(4):813-817. doi:10.1097/01.AOG.0000178754.88912.b9 - DOI - PubMed
    1. Dinger J, Bardenheuer K, Minh TD. Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer. Contraception. 2011;83(3):211-217. doi:10.1016/j.contraception.2010.11.009 - DOI - PubMed
    1. Soini T, Hurskainen R, Grénman S, et al. . Levonorgestrel-releasing intrauterine system and the risk of breast cancer: a nationwide cohort study. Acta Oncol. 2016;55(2):188-192. doi:10.3109/0284186X.2015.1062538 - DOI - PubMed
    1. Siegelmann-Danieli N, Katzir I, Landes JV, et al. . Does levonorgestrel-releasing intrauterine system increase breast cancer risk in peri-menopausal women? an HMO perspective. Breast Cancer Res Treat. 2018;167(1):257-262. doi:10.1007/s10549-017-4491-2 - DOI - PubMed

LinkOut - more resources